TAG:
labcorp and quest
Florida Pathology Group Lost Volume After BeaconLBS Started
By Joseph Burns | From the Volume XXIII No. 9 – July 5, 2016 Issue
CEO SUMMARY: A 22-physician pathology group in Tampa has complied with rules for lab test ordering that UnitedHealthcare and BeaconLBS established, yet has experienced a steep decline in the volume of specimens it receives. Physicians told the pathologists that other labs were not using t…
Florida AG Opposes Bill Over Customary Charges
By Joseph Burns | From the Volume XXIII, No. 2 – February 8, 2016 Issue
CEO SUMMARY: It was a surprise to the Florida Attorney General that a bill had surfaced in the Florida Legislature to amend the existing state lawās definition of usual and customary pricing to the Medicaid program. The bill would even make that change in definition retroactive. If this…
New DAT Law, Competition Heat Up Phoenix Market
By Joseph Burns | From the Volume XXII No. 15 – October 26, 2015 Issue
CEO SUMMARY: In Arizona, Theranos supported a new state law this year that allows patients to order lab tests without a doctorās order. Since the law took effect, that law and the ultra-low prices offered by Theranos are drawing away some cash-paying customers from one lab company that …
Labs Have Questions for CMS on Proposed Rule
By Joseph Burns | From the Volume XXII No. 14 – October 5, 2015 Issue
CEO SUMMARY: On September 25, CMS took a long overdue step to issue a proposed rule on how medical laboratories are to report private market prices for lab tests to the Medicare program during 2016. The proposed rule provides insights as to how CMS envisions pricing new tests and advanced…
LabCorp, Quest Diagnostics Both Say 2014 Revenue Was Up
By Robert Michel | From the Volume XXII No. 5 – March 30, 2015 Issue
BOTH OF THE NATION’S LARGEST clinical laboratory companies reported increased specimen volume as aĀ result of the Accountable Care Act (ACA), as noted in their respective fourth quarter and full-year earnings reports. First to issue its earning statement was Quest Diagnostics Incorporated. On…
Locked Out of Payer Network, NH Hospital Opens Lab Company
By Joseph Burns | From the Volume XXII No. 4 – March 9, 2015 Issue
CEO SUMMARY: Since Anthem launched its site of service program in New Hampshire in 2010, labs in the stateās hospitals have mostly been excluded from its network and have lost market share. Recently one community hospital developed an unusual strategy to win back those patients…
Is PAML to Be Sold? āNo Comment!ā Say Execs
By Robert Michel | From the Volume XXI No. 17 – December 15, 2014 Issue
CEO SUMMARY: It is one of the 10 largest lab companiesĀ in the United States. Thus, if Pathology Associates MedicalĀ Laboratories in Spokane, Washington, were to be sold, it wouldĀ trigger a major shift in the competitive market for lab testingĀ service…
Excluding Lab Competitors Helps Big Labs Grab Greater Market Share
By Joseph Burns | From the Volume XXI No. 9 – June 30, 2014 Issue
CEO SUMMARY: Changes in healthcare are motivating health insurers and the nationās largest lab testing companies to enter into contracts in which the large lab company lowers its lab test prices to the payer in return for having the payer exclude that lab companyās toughest competitor…
Competitive Bidding: Once Again, Itās Back!
By Robert Michel | From the Volume XIX No. 13 – September 17, 2012 Issue
CEO SUMMARY: For the clinical lab industry, the concept of competitive bidding for Medicare Part B Clinical Lab Testing may be like the movie āGroundhog Day.ā The hero, Bill Murray, kept reliving the same day over and over. So it seems to be with competitive bidding. In the latest rep…
LabCorp Inks Agreement In Medi-Cal Pricing Case
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
CEO SUMMARY: In its āSettlement Agreement and Releaseā with the California Attorney General (AG), Laboratory Corporation of America has negotiated terms that essentially match the agreement that exists between Quest Diagnostics Incorporated and the California AG. These settle…
CURRENT ISSUE
Volume XXXI, No. 12 – September 3, 2024
This special intelligence briefingāpresented in three partsāidentifies the factors retarding a faster adoption of digital pathology. Also, how to protect your labās proprietary LDTs and assess the financial impact of compliance.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized